Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Pathophysiology of human multiple myeloma--recent advances and future directions.

Barlogie B.

Curr Top Microbiol Immunol. 1992;182:245-50. Review. No abstract available.

PMID:
1490361
2.

Multiple myeloma: biology of the disease.

Mahindra A, Hideshima T, Anderson KC.

Blood Rev. 2010 Nov;24 Suppl 1:S5-11. doi: 10.1016/S0268-960X(10)70003-5. Review.

PMID:
21126636
3.

Recent advances in multiple myeloma.

Sjak-Shie NN, Vescio RA, Berenson JR.

Curr Opin Hematol. 2000 Jul;7(4):241-6. Review.

PMID:
10882180
4.

Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.

Gadó K, Domján G, Hegyesi H, Falus A.

Cell Biol Int. 2000;24(4):195-209. Review.

PMID:
10816321
5.

Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.

Klein B, Seckinger A, Moehler T, Hose D.

Recent Results Cancer Res. 2011;183:39-86. doi: 10.1007/978-3-540-85772-3_3. Review.

PMID:
21509680
6.

Cytokine network in human multiple myeloma.

Klein B, Bataille R.

Hematol Oncol Clin North Am. 1992 Apr;6(2):273-84. Review.

PMID:
1582974
7.

[Multiple myeloma--the biology of malignant plasma cells].

Paluszewska M.

Pol Arch Med Wewn. 1996 Jan;95(1):67-72. Review. Polish. No abstract available.

PMID:
8677197
8.

Multiple myeloma: almost all patients are cytogenetically abnormal.

Zandecki M, Laï JL, Facon T.

Br J Haematol. 1996 Aug;94(2):217-27. Review. No abstract available.

PMID:
8759879
9.

[Plasma cell myeloma. I. A new concept of disease biology].

Barlogi B, Epstein J, Selvaniagam P, Alexanian R.

Gematol Transfuziol. 1991 Aug;36(8):29-35. Review. Russian. No abstract available.

PMID:
1752407
10.

Recent progress in the biology of multiple myeloma and future directions in the treatment.

Pico JL, Castagna L, Bourhis JH.

Hematol Cell Ther. 1998 Apr;40(2):45-61. Review.

PMID:
9615247
11.

Lineage complexity in multiple myeloma?

Sahota SS, Stevenson FK.

Leuk Lymphoma. 2006 Sep;47(9):1997-8. Review. No abstract available.

PMID:
17065026
12.

[Implication of bone marrow microenvironment in pathogenesis of multiple myeloma].

Fišerová B, Kubiczková L, Sevčíková S, Hájek R.

Klin Onkol. 2012;25(4):234-40. Review. Czech.

PMID:
22920162
13.

Perspectives on the origins of multiple myeloma and plasmacytomas in mice.

Potter M.

Hematol Oncol Clin North Am. 1992 Apr;6(2):211-23. Review.

PMID:
1582969
14.

[The role of cytokines in differentiation and function of normal and pathologic plasmacytes].

Usnarska-Zubkiewicz L.

Pol Arch Med Wewn. 1996 Oct;96(4):395-405. Review. Polish. No abstract available.

PMID:
9082352
15.

[Multiple myeloma].

Krome S.

Dtsch Med Wochenschr. 2012 Mar;137 Suppl 1:S14-7. doi: 10.1055/s-0032-1301853. Epub 2012 Mar 21. Review. German. No abstract available.

PMID:
22438117
16.

Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma.

Klein B.

Semin Hematol. 1995 Jan;32(1):4-19. Review. No abstract available.

PMID:
7878477
17.

New insights in the clinical biology of multiple myeloma.

Bataille R.

Semin Hematol. 1997 Jan;34(1 Suppl 1):23-8. Review.

PMID:
9122743
18.

[Multiple myeloma. Mechanisms of proliferation and neoplastic progression and their clinical implications].

Boccadoro M, Battaglio S, Dianzani U, Frieri R, Gallone G, Massaia M, Omedè P, Palumbo A, Pileri A.

Haematologica. 1991 Jun;76 Suppl 3:100-6. Review. Italian. No abstract available.

PMID:
1752506
19.

In vitro growth of human multiple myeloma: implications for biology and therapy.

Caligaris-Cappio F, Gregoretti MG, Ghia P, Bergui L.

Hematol Oncol Clin North Am. 1992 Apr;6(2):257-71. Review.

PMID:
1582973
20.

Multiple myeloma, a model for fundamental and clinical research.

Vande Broek I, Asosingh K, Vanderkerken K, Van Riet I, Van Camp B.

Verh K Acad Geneeskd Belg. 2002;64(4):261-84; discussion 284-6. Review.

PMID:
12416235

Supplemental Content

Support Center